Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1989-12-19
1991-11-12
Lovering, Richard D.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
534 10, 252625, A61K 4300, C07F 500
Patent
active
050646338
ABSTRACT:
Particle emitting radionuclides, e.g. X-90, have been complexed with certain macrocyclic aminophosphonic acids wherein the nitrogen and phosphorus are interconnected by an alkylene group or substituted alkylene group. These complexes have been found useful in compositions and formulations for the therapeutic treatment of calcific tumors and the relief of bone pain in animals.
REFERENCES:
patent: 4639365 (1987-01-01), Sherry
patent: 4647447 (1987-03-01), Gries et al.
patent: 4678667 (1987-07-01), Meares et al.
patent: 4808541 (1989-02-01), Mikola et al.
patent: 4882142 (1989-11-01), Simon
patent: 4885363 (1989-12-01), Tweedle et al.
patent: 4897254 (1990-01-01), Simon et al.
patent: 4898724 (1990-02-01), Simon et al.
Inorganic Chimica Acta 137-139 (1987).
J. Magn. Reson. 76, 528 (1988).
Inorganic Chem 28(17), 3336-3341 (1989).
Garlich Joseph R.
Simon Jaime
Troutner David E.
Wilson David A.
Covert John M.
Kimble Karen L.
Lovering Richard D.
The Dow Chemical Company
LandOfFree
Macrocyclic aminophosphonic acid complexes, their formulations a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Macrocyclic aminophosphonic acid complexes, their formulations a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Macrocyclic aminophosphonic acid complexes, their formulations a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1011923